PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
about
Mapping biological behaviors by application of longer-lived positron emitting radionuclidesImaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesDetection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPETOncologic Angiogenesis Imaging in the clinic---how and why.Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumabHER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.86Y based PET radiopharmaceuticals: radiochemistry and biological applicationsPositron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?Tumour targeting with radiometals for diagnosis and therapy.Matching chelators to radiometals for radiopharmaceuticals.Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets.Current molecular imaging positron emitting radiotracers in oncology.Molecular imaging in ovarian cancer.C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma.Beyond the margins: real-time detection of cancer using targeted fluorophores.Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.Efficient route to pre-organized and linear polyaminopolycarboxylates: Cy-TTHA, Cy-DTPA and mono/di- reactive, tert-butyl protected TTHA/Cy-TTHA.Preclinical evaluation of holmium-166 labeled anti-VEGF-A(Bevacizumab).Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
P2860
Q26824070-5985B630-2790-42CF-BFE4-CB8156F3265EQ28384090-9693CDC6-FACD-4735-A5E1-47E7C45D51C7Q28487987-EAC801F0-5DE6-4DD5-95A4-AA5F91172B24Q30472751-FE9FB067-952A-442A-B7B7-7DB49F527084Q33740232-216D3AEE-78CD-4076-AAF8-2E651C3CAE54Q33862523-DB323F01-9B04-437E-A808-3631AFB35DA5Q34216877-94B3E389-449C-41A5-B5FA-C3158BB57A3EQ35250409-786DB082-A304-4169-AF2B-550F5FD64987Q35646547-1E79A4F6-7998-41DE-BD5F-00254E0CFF64Q37102447-D9FE198B-AA11-4AD8-AE4F-15D7A82723D8Q37236103-20B9643A-000A-446A-97DC-1C5EC7C3A19CQ37860943-5B2C6D5E-4EAA-4345-B87D-DF1ED859AA78Q37864161-7EC08AB8-101D-4F5E-853E-FA978B206726Q38100112-659479A5-FCB9-4F89-A0DE-A3C5E9A022F0Q38156660-435CDC48-7BC7-4535-8544-28463684378AQ38205041-15D0896E-053D-4A52-8A3E-43F8AA124821Q38217835-B79D002B-59F7-4E41-AD37-F9FC7C916614Q38824319-8326456C-CB11-4BCC-A56D-14E609D1C71DQ38941602-65D6C256-BC79-412D-B95D-357F7149D06FQ39091749-27CA112B-691A-4D2C-A8A6-5F2ED9BC4123Q39221164-5D42484A-27AB-4551-9984-0CEDA69FBB26Q41485304-D21AB285-EBA1-4933-B220-D0ABBA429DADQ49613737-B932881F-92AB-44EC-8793-E2948FB71DC6Q53087436-B76F3A8B-9013-41B1-B70B-90B4C35F95A8Q58796699-2B8B5DE9-A756-4486-95A8-BFD875D2F4F1
P2860
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@ast
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@en
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted
@nl
type
label
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@ast
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@en
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted
@nl
prefLabel
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@ast
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab.
@en
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted
@nl
P2093
P2860
P356
P1476
PET imaging of tumor angiogene ...... (86)Y-CHX-A″-DTPA-bevacizumab
@en
P2093
Diane E Milenic
Kayhan Garmestani
Kwamena E Baidoo
Martin W Brechbiel
P2860
P304
P356
10.1002/IJC.25409
P577
2011-02-01T00:00:00Z